These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 20087340)

  • 1. A side effect resource to capture phenotypic effects of drugs.
    Kuhn M; Campillos M; Letunic I; Jensen LJ; Bork P
    Mol Syst Biol; 2010; 6():343. PubMed ID: 20087340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SIDER database of drugs and side effects.
    Kuhn M; Letunic I; Jensen LJ; Bork P
    Nucleic Acids Res; 2016 Jan; 44(D1):D1075-9. PubMed ID: 26481350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building the process-drug-side effect network to discover the relationship between biological processes and side effects.
    Lee S; Lee KH; Song M; Lee D
    BMC Bioinformatics; 2011 Mar; 12 Suppl 2(Suppl 2):S2. PubMed ID: 21489221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug target identification using side-effect similarity.
    Campillos M; Kuhn M; Gavin AC; Jensen LJ; Bork P
    Science; 2008 Jul; 321(5886):263-6. PubMed ID: 18621671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale automatic extraction of side effects associated with targeted anticancer drugs from full-text oncological articles.
    Xu R; Wang Q
    J Biomed Inform; 2015 Jun; 55():64-72. PubMed ID: 25817969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
    Yang CC; Zhao M
    Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation and analysis of indication-symptom relationships for drugs approved in the USA.
    Punyala A; Lankapalli R; Hindman D; Racz R
    Eur J Clin Pharmacol; 2020 Sep; 76(9):1291-1299. PubMed ID: 32495081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IntSide: a web server for the chemical and biological examination of drug side effects.
    Juan-Blanco T; Duran-Frigola M; Aloy P
    Bioinformatics; 2015 Feb; 31(4):612-3. PubMed ID: 25380960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic web technologies.
    Jiang G; Wang L; Liu H; Solbrig HR; Chute CG
    Stud Health Technol Inform; 2013; 192():496-500. PubMed ID: 23920604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicines containing pharmaceutical excipients with known effects: a French review.
    Fusier I; Tollier C; Husson MC
    Pharm World Sci; 2003 Aug; 25(4):152-5. PubMed ID: 12964493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.
    Vilar S; Tatonetti NP; Hripcsak G
    Sci Rep; 2015 Mar; 5():8809. PubMed ID: 25744369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
    Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse Effect Predictions Based on Computational Toxicology Techniques and Large-scale Databases].
    Uesawa Y
    Yakugaku Zasshi; 2018; 138(2):185-190. PubMed ID: 29386432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.
    Jang G; Lee T; Hwang S; Park C; Ahn J; Seo S; Hwang Y; Yoon Y
    J Biomed Inform; 2018 Nov; 87():96-107. PubMed ID: 30268842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WITHDRAWN--a resource for withdrawn and discontinued drugs.
    Siramshetty VB; Nickel J; Omieczynski C; Gohlke BO; Drwal MN; Preissner R
    Nucleic Acids Res; 2016 Jan; 44(D1):D1080-6. PubMed ID: 26553801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm.
    Shin H; Cha J; Lee Y; Kim JY; Lee S
    Health Informatics J; 2021; 27(3):14604582211033014. PubMed ID: 34289723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STITCH: interaction networks of chemicals and proteins.
    Kuhn M; von Mering C; Campillos M; Jensen LJ; Bork P
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D684-8. PubMed ID: 18084021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of data mining.
    Bone A; Houck K
    Elife; 2017 Aug; 6():. PubMed ID: 28813246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.